脑部放疗,上午比下午敏感许多!4 F% }: o2 s* J0 A y2 F
( h% J# ?8 R0 o, {" g' Y
, l, y; U3 A2 H" lCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
9 [. c7 }+ [: N. v& XGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?' `$ p" r( [6 g3 _, T6 H Z' {
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.( ~& U5 ]) x- q) Q7 J% {7 H. Z; a
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
0 w' v3 ^: w3 v; f6 U2 ?" N
( e* B0 m: `( H. p. ZAbstract# s# O* X1 W: {4 Y" L% F7 F# C, Q
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.# k: t; }- R, I- S i
2 |+ A' U7 w$ C7 `; ]' U' O# d
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic. P; x) P) }! b, @4 }0 {
4 w3 N0 f8 ] c" M5 R3 f9 C: X' hRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).( T# T1 e- e9 s
) m4 F# d0 r+ q6 Z N& D
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series., r) `/ S$ T6 [ S5 Q
) |! `# o+ e" y# N0 p
|